Skip to Content

Workers’ Compensation Board

Search menu

Save the Date – COVID-19 and Workers’ Compensation Webinar

Subject Number 046-1242 Temporary Suspension of Dr. Michael A. Schwartz

Subject Numbers Regarding Health Provider Authorizations

Authorization No. 232106-5W

December 30, 2019

Pursuant to Workers' Compensation Law Section 13-d(4), the Chair of the New York State Workers' Compensation Board has exercised her authority to temporarily suspend Dr. Michael A. Schwartz’s authorization to treat injured workers within the New York State workers’ compensation system effective December 30, 2019. Dr. Schwartz's last known business addresses are:

222 Westchester Avenue, Suite 101
White Plains, New York 10604


1296 North Avenue, 1st Floor
New Rochelle, New York 10804

The Chair’s designee’s investigation has revealed that, despite multiple written requests, Dr. Schwartz has failed and refused to provide the Board with proof of reimbursement of the sum of $1,655.66 to claimant’s private health insurer, which sum having also been paid to Dr. Schwartz by the claimant’s workers’ compensation carrier for the same treatment.

As a result of the foregoing, the Chair believes that Dr. Schwartz may be guilty of misconduct under WCL §13-d(2)(f) for the refusal to produce “any relevant book or paper concerning his or her conduct under any authorization granted to him or her under this chapter.”

Dr. Schwartz is prohibited from rendering treatment and care to injured workers and from conducting reviews of records regarding variance requests pursuant to 12 NYCRR § 324.3(b)(2)(ii)(a) while his authorization is temporarily suspended. Reports submitted by Dr. Schwartz for services rendered prior to December 30, 2019, are valid, but are invalid for any services rendered on or after that date. Requests to cross-examine Dr. Schwartz for services rendered prior to December 30, 2019, should not be denied due to the suspension of his authorization.

This suspension remains in effect until further notice. Any questions regarding the authorized lists should be referred to the Medical Director’s Office at 1 (800) 781-2362.

Clarissa M. Rodriguez